Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.33 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25516861 | 0.96 | CYP1A1 (0.33) | CYP1A1CYP1A2FYNMAPK3AHR | |
| SCHEMBL25516586 | 0.91 | ABCG2 (0.33) | CYP1A1CYP1A2FYNMAPK3AHR | |
| SCHEMBL27049908 | 0.91 | ABCG2 (0.34) | CYP1A1CYP1A2FYNMAPK3AHR | |
| SCHEMBL25517032 | 0.90 | ABCG2 (0.33) | CYP1A1CYP1A2FYNMAPK3AHR | |
| SCHEMBL26359689 | 0.90 | ABCG2 (0.33) | CYP1A1CYP1A2FYNMAPK3AHR | |
| SCHEMBL25516383 | 0.89 | ABCG2 (0.36) | CYP1A1CYP1A2FYNMAPK3AHR | |
| SCHEMBL25516588 | 0.89 | ABCG2 (0.36) | CYP1A1CYP1A2FYNMAPK3AHR | |
| SCHEMBL21707699 | 0.87 | KDM4E (0.32) | AHR | |
| SCHEMBL26359511 | 0.87 | ABCG2 (0.35) | CYP1A1CYP1A2FYNMAPK3AHR | |
| SCHEMBL25516860 | 0.86 | CYP1A1 (0.32) | CYP1A1CYP1A2FYNMAPK3AHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240215441-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2024-06-27 | — | — | US | disclosed |
| WO-2023085881-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2023-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240215441-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY2, CRY1, AHR | CYP1A1 6/4885CYP1A2 33/4885FYN 2769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.